sctc21c
mAbexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Feb 28, 2024 (NCT06252298)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07297329 | Phase 3 | Dec 31, 2025 | Sinocelltech Ltd. |
| NCT06774664 | Phase 1/Phase 2 (Phase 2) | Jan 31, 2025 | Sinocelltech Ltd. |
| NCT06252298 | Phase 1 | Feb 28, 2024 | Sinocelltech Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sinocelltech Ltd. | For profit | 3 | 3 | 3 | 2024 |
1 organizations
Page 1 / 1